Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The aldosterone receptor (MR), also known as NR3C2, is a nuclear hormone receptor that functions as a ligand-activated transcription factor. It plays a key role in regulating sodium reabsorption, potassium excretion, and blood pressure, primarily in the kidney, colon, heart, and central nervous system. Aldosterone is the primary physiological agonist, although cortisol and corticosterone can also bind with high affinity. Selectivity for aldosterone is achieved in some tissues by the enzyme 11β-HSD2. Antagonists like spironolactone and eplerenone are used therapeutically for conditions such as heart failure and hypertension. Mutations or overactivation of the MR can lead to hypertension and hypokalemia.
Ligand binds to cytoplasmic MR, complex translocates into nucleus, binds hormone response elements on DNA, and modulates transcription of target genes.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aldosterone Receptor (MR).